The biology of interleukin-2.

Much data support an essential role for interleukin (IL)-2 in immune tolerance. This idea is much different from the early paradigm in which IL-2 is central for protective immune responses. This change in thinking occurred when a T regulatory cell defect was shown to be responsible for the lethal autoimmunity associated with IL-2/IL-2R deficiency. This realization allowed investigators to explore immune responses in IL-2-nonresponsive mice rendered autoimmune-free. Such studies established that IL-2 sometimes contributes to optimal primary immune responses, but it is not mandatory. Emerging findings, however, suggest an essential role for IL-2 in immune memory. Here, the current understanding of the dual role of IL-2 in maintaining tolerance and contributing to immunity in vivo is reviewed with some emphasis on T regulatory cell production and homeostasis. Also discussed are implications of this new appreciation concerning the immunobiology of IL-2 with respect to targeting IL-2 or its receptor in immunotherapy.

[1]  E. Rothenberg,et al.  A New Regulatory Region of the IL-2 Locus That Confers Position-Independent Transgene Expression1 , 2001, The Journal of Immunology.

[2]  D. Rosenstreich,et al.  Uromodulin, an immunosuppressive protein derived from pregnancy urine, is an inhibitor of interleukin 1. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[3]  C. Klebanoff,et al.  Interleukin-2-Dependent Mechanisms of Tolerance and Immunity In Vivo1 , 2006, The Journal of Immunology.

[4]  A. C. Webb,et al.  Genomic sequence for human prointerleukin 1 beta: possible evolution from a reverse transcribed prointerleukin 1 alpha gene. , 1986, Nucleic acids research.

[5]  S. Mizel,et al.  The interleukin 1 receptor. Dynamics of interleukin 1 binding and internalization in T cells and fibroblasts. , 1987, Journal of immunology.

[6]  T. Malek,et al.  CD4 regulatory T cells prevent lethal autoimmunity in IL-2Rbeta-deficient mice. Implications for the nonredundant function of IL-2. , 2002, Immunity.

[7]  A. Rudensky,et al.  Foxp3 programs the development and function of CD4+CD25+ regulatory T cells , 2003, Nature Immunology.

[8]  C. Dinarello,et al.  Increased plasma interleukin-1 activity in women after ovulation. , 1985, Science.

[9]  K. Schwarz,et al.  Differential role of IL‐2R signaling for CD8+ T cell responses in acute and chronic viral infections , 2007, European journal of immunology.

[10]  K. White,et al.  Interleukin 2 promoter/enhancer controlled expression of a synthetic cecropin-class lytic peptide in transgenic mice and subsequent resistance to Brucella abortus , 1997, Transgenic Research.

[11]  K. Calame,et al.  Transcriptional repressor Blimp-1 regulates T cell homeostasis and function , 2006, Nature Immunology.

[12]  R. Gallo,et al.  Selective in vitro growth of T lymphocytes from normal human bone marrows. , 1976, Science.

[13]  C. Mawrin,et al.  Systemic lupus erythematosus serum IgG increases CREM binding to the IL-2 promoter and suppresses IL-2 production through CaMKIV. , 2005, The Journal of clinical investigation.

[14]  S. Ziegler,et al.  IL‐2Rβ links IL‐2R signaling with Foxp3 expression , 2007 .

[15]  T. Nomura,et al.  Control of Regulatory T Cell Development by the Transcription Factor Foxp3 , 2002 .

[16]  L. Glimcher,et al.  IL-2 production in developing Th1 cells is regulated by heterodimerization of RelA and T-bet and requires T-bet serine residue 508 , 2005, The Journal of experimental medicine.

[17]  D. Kioussis,et al.  Thymic selection and peptide‐induced activation of T cell receptor‐transgenic CD8 T cells in interleukin‐2‐deficient mice , 1994, European journal of immunology.

[18]  T. Geiger,et al.  Uncoupling of IL-2 Signaling from Cell Cycle Progression in Naive CD4+ T Cells by Regulatory CD4+CD25+ T Lymphocytes1 , 2005, The Journal of Immunology.

[19]  T. Malek,et al.  The Proteasome Regulates Receptor-mediated Endocytosis of Interleukin-2* , 2001, The Journal of Biological Chemistry.

[20]  Vincent C. Manganiello,et al.  Foxp3-dependent programme of regulatory T-cell differentiation , 2007, Nature.

[21]  E. Shevach,et al.  Activation requirements for the induction of CD4+CD25+ T cell suppressor function , 2004, European journal of immunology.

[22]  H. Griesser,et al.  Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor beta. , 1995, Science.

[23]  T. Taniguchi,et al.  Structure and expression of a cloned cDNA for human interleukin-2 , 1983, Nature.

[24]  C. June,et al.  Clinical application of expanded CD4+25+ cells. , 2006, Seminars in immunology.

[25]  A. Rudensky,et al.  Effects of the Administration of High-Dose Interleukin-2 on Immunoregulatory Cell Subsets in Patients with Advanced Melanoma and Renal Cell Cancer , 2007, Clinical Cancer Research.

[26]  J. Sprent,et al.  Selective Stimulation of T Cell Subsets with Antibody-Cytokine Immune Complexes , 2006, Science.

[27]  T. Chatila,et al.  Regulatory T cell development in the absence of functional Foxp3 , 2007, Nature Immunology.

[28]  G. Leclercq,et al.  Developmental and Functional Defects of Thymic and Epidermal Vγ3 Cells in IL-15-Deficient and IFN Regulatory Factor-1-Deficient Mice1 , 2002, The Journal of Immunology.

[29]  D. Baltimore,et al.  Essential Role for STAT5 Signaling in CD25+CD4+ Regulatory T Cell Homeostasis and the Maintenance of Self-Tolerance1 , 2003, The Journal of Immunology.

[30]  T. Daikoku,et al.  Memory-Type CD8+ T Cells Protect IL-2 Receptor α-Deficient Mice from Systemic Infection with Herpes Simplex Virus Type 21 , 2000, The Journal of Immunology.

[31]  B. Nelson,et al.  Biology of the interleukin-2 receptor. , 1998, Advances in immunology.

[32]  H. Weiner,et al.  Th3 Cells in Peripheral Tolerance. II. TGF-β-Transgenic Th3 Cells Rescue IL-2-Deficient Mice from Autoimmunity1 , 2007, The Journal of Immunology.

[33]  J. Berzofsky,et al.  Lymphopenia and interleukin-2 therapy alter homeostasis of CD4+CD25+ regulatory T cells , 2005, Nature Medicine.

[34]  P. Nickerson,et al.  IL-2 knockout recipient mice reject islet cell allografts. , 1995, Journal of immunology.

[35]  C. Karagiannidis,et al.  Molecular Mechanisms Underlying FOXP3 Induction in Human T Cells1 , 2006, The Journal of Immunology.

[36]  J. Ortaldo,et al.  Glucocorticoid amplifies IL‐2‐dependent expansion of functional FoxP3+CD4+CD25+ T regulatory cells in vivo and enhances their capacity to suppress EAE , 2006, European journal of immunology.

[37]  Peter R. Galle,et al.  Cutting Edge: TGF-β Induces a Regulatory Phenotype in CD4+CD25− T Cells through Foxp3 Induction and Down-Regulation of Smad7 , 2004, The Journal of Immunology.

[38]  A. Singer,et al.  CD28 costimulation of developing thymocytes induces Foxp3 expression and regulatory T cell differentiation independently of interleukin 2 , 2005, Nature Immunology.

[39]  S. Burakoff,et al.  Involvement of Proteasomes in Regulating Jak-STAT Pathways upon Interleukin-2 Stimulation* , 1997, The Journal of Biological Chemistry.

[40]  D. Cantrell,et al.  The interleukin-2 T-cell system: a new cell growth model. , 1984, Science.

[41]  S. Rosenberg,et al.  IL-2 administration increases CD4+ CD25(hi) Foxp3+ regulatory T cells in cancer patients. , 2006, Blood.

[42]  O. Lantz,et al.  γ chain required for naïve CD4+ T cell survival but not for antigen proliferation , 2000, Nature Immunology.

[43]  T. Malek,et al.  IL-2Rβ/IL-7Rα Doubly Deficient Mice Recapitulate the Thymic and Intraepithelial Lymphocyte (IEL) Developmental Defects of γc−/− Mice: Roles for Both IL-2 and IL-15 in CD8αα IEL Development , 1999, The Journal of Immunology.

[44]  A. C. Webb,et al.  Transcriptional regulation of the human prointerleukin 1 beta gene. , 1987, Journal of immunology.

[45]  H. Dadi,et al.  Human immune disorder arising from mutation of the α chain of the interleukin-2 receptor , 1997 .

[46]  R. Gress,et al.  Suppression of T cell function: a potential role for transcriptional repressor ICER , 2000, Journal of leukocyte biology.

[47]  J. Bluestone,et al.  Regulatory T‐cell physiology and application to treat autoimmunity , 2006, Immunological reviews.

[48]  L. Lachman,et al.  Subcellular localization of human monocyte interleukin 1: evidence for an inactive precursor molecule and a possible mechanism for IL 1 release. , 1987, Journal of immunology.

[49]  G. Crabtree,et al.  Regulation of interleukin-2 gene enhancer activity by the T cell accessory molecule CD28. , 1991, Science.

[50]  H. Waldmann,et al.  Regulating the immune response to transplants. a role for CD4+ regulatory cells? , 2001, Immunity.

[51]  P. Ghezzi,et al.  Recombinant tumor necrosis factor/cachectin and interleukin 1 pretreatment decreases lung oxidized glutathione accumulation, lung injury, and mortality in rats exposed to hyperoxia. , 1987, The Journal of clinical investigation.

[52]  S. Zheng,et al.  Natural and Induced CD4+CD25+ Cells Educate CD4+CD25− Cells to Develop Suppressive Activity: The Role of IL-2, TGF-β, and IL-101 , 2004, The Journal of Immunology.

[53]  M. Battaglia,et al.  Rapamycin Promotes Expansion of Functional CD4+CD25+FOXP3+ Regulatory T Cells of Both Healthy Subjects and Type 1 Diabetic Patients1 , 2006, The Journal of Immunology.

[54]  B. Nelson,et al.  Proliferation and Differentiation of CD8+ T Cells in the Absence of IL-2/15 Receptor β-Chain Expression or STAT5 Activation , 2004, The Journal of Immunology.

[55]  R. Nussenblatt,et al.  Cutting Edge: In Vivo Blockade of Human IL-2 Receptor Induces Expansion of CD56bright Regulatory NK Cells in Patients with Active Uveitis , 2005, The Journal of Immunology.

[56]  C. Weaver,et al.  Visualization of antigen-specific T cell activation and cytokine expression in vivo. , 1997, Journal of immunology.

[57]  D. Fearon,et al.  CD27 mediates interleukin-2-independent clonal expansion of the CD8+ T cell without effector differentiation , 2006, Proceedings of the National Academy of Sciences.

[58]  A. Khoruts,et al.  A Natural Immunological Adjuvant Enhances T Cell Clonal Expansion through a CD28-dependent, Interleukin (IL)-2–independent Mechanism , 1998, The Journal of experimental medicine.

[59]  M. Farrar,et al.  Distinct IL-2 Receptor Signaling Pattern in CD4+CD25+ Regulatory T Cells1 , 2004, The Journal of Immunology.

[60]  J. Yodoi,et al.  Down-regulation of interleukin 1 (IL 1) receptor expression by IL 1 and fate of internalized 125I-labeled IL 1 beta in a human large granular lymphocyte cell line. , 1986, Journal of immunology.

[61]  T. Hünig,et al.  Control of T cell hyperactivation in IL‐2‐deficient mice by CD4+CD25– and CD4+CD25+ T cells: evidence for two distinct regulatory mechanisms , 2001, European journal of immunology.

[62]  M. Goldsmith,et al.  Loss of Tolerance and Autoimmunity Affecting Multiple Organs in STAT5A/5B-Deficient Mice 1 , 2003, The Journal of Immunology.

[63]  M. Lenardo.  lnterleukin-2 programs mouse αβ T lymphocytes for apoptosis , 1991, Nature.

[64]  H. Young,et al.  Intracellular localization of human monocyte associated interleukin 1 (IL 1) activity and release of biologically active IL 1 from monocytes by trypsin and plasmin. , 1986, Journal of immunology.

[65]  S. Krane,et al.  Mononuclear cell-conditioned medium containing mononuclear cell factor (MCF), homologous with interleukin 1, stimulates collagen and fibronectin synthesis by adherent rheumatoid synovial cells: effects of prostaglandin E2 and indomethacin. , 1985, Collagen and related research.

[66]  T. Malek,et al.  Broad Programming by IL-2 Receptor Signaling for Extended Growth to Multiple Cytokines and Functional Maturation of Antigen-Activated T Cells1 , 2001, The Journal of Immunology.

[67]  J. Dayer,et al.  Prostaglandin E2 and collagenase production by fibroblasts and synovial cells is regulated by urine-derived human interleukin 1 and inhibitor(s). , 1986, The Journal of clinical investigation.

[68]  B. Foxwell,et al.  A Late, Prolonged Activation of the Phosphatidylinositol 3-Kinase Pathway Is Required for T Cell Proliferation1 , 2004, The Journal of Immunology.

[69]  S. Gaffen.  Signaling domains of the interleukin 2 receptor. , 2001, Cytokine.

[70]  E. Wherry,et al.  Therapeutic use of IL-2 to enhance antiviral T-cell responses in vivo , 2003, Nature Medicine.

[71]  L. Bradley,et al.  Interleukin 7 Regulates the Survival and Generation of Memory CD4 Cells , 2003, The Journal of experimental medicine.

[72]  S. Swain,et al.  IL-7 Promotes the Transition of CD4 Effectors to Persistent Memory Cells , 2003, The Journal of experimental medicine.

[73]  S. Sakaguchi.  Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses. , 2004, Annual review of immunology.

[74]  C. Roifman.  Human IL-2 Receptor α Chain Deficiency , 2000, Pediatric Research.

[75]  A. Vander,et al.  Suppression of food intake during infection: is interleukin-1 involved? , 1985, The American journal of clinical nutrition.

[76]  Yu Wang,et al.  Hassall's corpuscles instruct dendritic cells to induce CD4+CD25+ regulatory T cells in human thymus , 2005, Nature.

[77]  I. Gery,et al.  POTENTIATION OF THE T-LYMPHOCYTE RESPONSE TO MITOGENS , 1972, The Journal of experimental medicine.

[78]  A. C. Webb,et al.  Studies on the molecular nature of human interleukin 1. , 1987, Journal of immunology.

[79]  M. Farrar,et al.  Distinct Effects of STAT5 Activation on CD4+ and CD8+ T Cell Homeostasis: Development of CD4+CD25+ Regulatory T Cells versus CD8+ Memory T Cells 1 , 2003, The Journal of Immunology.

[80]  Kendall A. Smith,et al.  Long term culture of tumour-specific cytotoxic T cells , 1977, Nature.

[81]  J. Rogers,et al.  Interleukin-2 gene variation impairs regulatory T cell function and causes autoimmunity , 2007, Nature Genetics.

[82]  T. Mak,et al.  Normal thymic selection, superantigen-induced deletion and Fas-mediated apoptosis of T cells in IL-2 receptor beta chain-deficient mice. , 1997, International immunology.

[83]  E Morelon,et al.  Endocytosis of interleukin 2 receptors in human T lymphocytes: distinct intracellular localization and fate of the receptor alpha, beta, and gamma chains , 1995, The Journal of cell biology.

[84]  T. Malek,et al.  Cytokine-Dependent Blimp-1 Expression in Activated T Cells Inhibits IL-2 Production1 , 2007, The Journal of Immunology.

[85]  H. Koenen,et al.  Following Anti‐CD25 Treatment, A Functional CD4+CD25+ Regulatory T‐Cell Pool Is Present in Renal Transplant Recipients , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[86]  J. Bluestone,et al.  B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. , 2000, Immunity.

[87]  A. Rao,et al.  Transcriptional regulation of the IL-2 gene. , 1995, Current opinion in immunology.

[88]  S. Zheng,et al.  IL-2 Is Essential for TGF-β to Convert Naive CD4+CD25− Cells to CD25+Foxp3+ Regulatory T Cells and for Expansion of These Cells1 , 2007, The Journal of Immunology.

[89]  K. Nadeau,et al.  Cutting Edge: Decreased Accumulation and Regulatory Function of CD4+CD25high T Cells in Human STAT5b Deficiency1 , 2006, The Journal of Immunology.

[90]  M. Bevan,et al.  Effector and memory CTL differentiation. , 2007, Annual review of immunology.

[91]  E. Shevach,et al.  Cutting Edge: IL-2 Is Essential for TGF-β-Mediated Induction of Foxp3+ T Regulatory Cells , 2007, The Journal of Immunology.

[92]  T. Malek,et al.  Cutting Edge: Allogeneic CD4+CD25+Foxp3+ T Regulatory Cells Suppress Autoimmunity while Establishing Transplantation Tolerance1 , 2006, The Journal of Immunology.

[93]  S. Rutz,et al.  Interleukin‐2 is essential for CD4+CD25+ regulatory T cell function , 2004, European journal of immunology.

[94]  Ana Cumano,et al.  CD25+ CD4+ T Cells Regulate the Expansion of Peripheral CD4 T Cells Through the Production of IL-101 , 2001, The Journal of Immunology.

[95]  R. Zinkernagel,et al.  Immune responses in interleukin-2-deficient mice. , 1993, Science.

[96]  J. Stroud,et al.  FOXP3 Controls Regulatory T Cell Function through Cooperation with NFAT , 2006, Cell.

[97]  T. Kadesch,et al.  Transcriptional repression of the IL-2 gene in Th cells by ZEB. , 1998, Journal of immunology.

[98]  K. Kretschmer,et al.  Instruction of Treg commitment in peripheral T cells is suited to reverse autoimmunity. , 2006, Seminars in immunology.

[99]  T. Williams,et al.  Identification of a zinc finger protein that inhibits IL-2 gene expression. , 1991, Science.

[100]  T. Nomura,et al.  Foxp3 controls regulatory T-cell function by interacting with AML1/Runx1 , 2007, Nature.

[101]  P. Lomedico,et al.  Cloning and expression of murine interleukin-1 cDNA in Escherichia coli , 1984, Nature.

[102]  B. Nelson,et al.  Enhanced signaling through the IL-2 receptor in CD8+ T cells regulated by antigen recognition results in preferential proliferation and expansion of responding CD8+ T cells rather than promotion of cell death , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[103]  Z. Dai,et al.  Impaired alloantigen-mediated T cell apoptosis and failure to induce long-term allograft survival in IL-2-deficient mice. , 1998, Journal of immunology.

[104]  J. Nerup,et al.  Affinity-purified human Interleukin I is cytotoxic to isolated islets of Langerhans , 2006, Diabetologia.

[105]  J. Saklatvala,et al.  Studies on the fate of receptor-bound 125I-interleukin 1 beta in porcine synovial fibroblasts. , 1987, Journal of immunology.

[106]  S. Nutt,et al.  Transcriptional repressor Blimp-1 is essential for T cell homeostasis and self-tolerance , 2006, Nature Immunology.

[107]  W. Leonard,et al.  Smad-dependent Cooperative Regulation of Interleukin 2 Receptor α Chain Gene Expression by T Cell Receptor and Transforming Growth Factor-β* , 2005, Journal of Biological Chemistry.

[108]  E. Pamer,et al.  Disparate In Vitro and In Vivo Requirements for IL-2 During Antigen-Independent CD8 T Cell Expansion1 , 2004, The Journal of Immunology.

[109]  C. Thompson,et al.  Regulation of lymphokine messenger RNA stability by a surface-mediated T cell activation pathway. , 1989, Science.

[110]  T. Malek,et al.  Efficient Induction of Primary and Secondary T Cell-Dependent Immune Responses In Vivo in the Absence of Functional IL-2 and IL-15 Receptors1 , 2003, The Journal of Immunology.

[111]  I. Nakashima,et al.  Mice Lacking Interleukin-2 (IL-2)/IL-15 Receptor β Chain Are Susceptible to Infection with Avirulent Salmonella enterica subsp. enterica Serovar Choleraesuis but Mice Lacking IL-2 Are Resistant , 2001, Infection and Immunity.

[112]  A. Rudensky,et al.  Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3 , 2007, Nature Immunology.

[113]  L. Lefrançois,et al.  IL-2 Is Not Required for the Initiation of CD8 T Cell Cycling but Sustains Expansion 1 , 2003, The Journal of Immunology.

[114]  C. Pénit,et al.  Regulatory Cd4 T Cells: Expression of Il-2rα Chain, Resistance to Clonal Deletion and Il-2 Dependency , 1998 .

[115]  A. Liston,et al.  Tracing the action of IL‐2 in tolerance to islet‐specific antigen , 2007, Immunology and cell biology.

[116]  K. Christopher Garcia,et al.  The Structure of Interleukin-2 Complexed with Its Alpha Receptor , 2005, Science.

[117]  M. Neumann,et al.  The architecture of the interleukin-2 promoter: a reflection of T lymphocyte activation. , 1995, Biochimica et biophysica acta.

[118]  E. Stanley,et al.  Regulation of very primitive, multipotent, hemopoietic cells by hemopoietin-1 , 1986, Cell.

[119]  T. Malek,et al.  Normal Lymphoid Homeostasis and Lack of Lethal Autoimmunity in Mice Containing Mature T Cells with Severely Impaired IL-2 Receptors1 , 2000, The Journal of Immunology.

[120]  Maria Persico,et al.  Inducible IL-2 production by dendritic cells revealed by global gene expression analysis , 2001, Nature Immunology.

[121]  A. Rudensky,et al.  Homeostasis and anergy of CD4+CD25+ suppressor T cells in vivo , 2002, Nature Immunology.

[122]  A. Tyznik,et al.  Interleukin-2 signals during priming are required for secondary expansion of CD8+ memory T cells , 2006, Nature.

[123]  J. Lafaille,et al.  Interleukin 2 Signaling Is Required for CD4+ Regulatory T Cell Function , 2002, The Journal of experimental medicine.

[124]  Y. Chien,et al.  Differential Roles of Cytokine Receptors in the Development of Epidermal γδ T Cells1 , 2001, The Journal of Immunology.

[125]  V. Paetkau,et al.  Mechanisms regulating the level of IL-2 mRNA in T lymphocytes. , 1988, Journal of immunology.

[126]  A. Rudensky,et al.  Developmental regulation of Foxp3 expression during ontogeny , 2005, The Journal of experimental medicine.

[127]  M. Caligiuri,et al.  Selective modulation of human natural killer cells in vivo after prolonged infusion of low dose recombinant interleukin 2. , 1993, The Journal of clinical investigation.

[128]  A. Rudensky,et al.  A function for interleukin 2 in Foxp3-expressing regulatory T cells , 2005, Nature Immunology.

[129]  M. Veldhoen,et al.  CD25+ CD4+ T cells compete with naive CD4+ T cells for IL-2 and exploit it for the induction of IL-10 production. , 2005, International immunology.

[130]  J. Ritz,et al.  IL-2 regulates FOXP3 expression in human CD4+CD25+ regulatory T cells through a STAT-dependent mechanism and induces the expansion of these cells in vivo. , 2006, Blood.

[131]  D. Mancini,et al.  Anti-CD25 treatment and FOXP3-positive regulatory T cells in heart transplantation. , 2007, Transplant immunology.

[132]  Antonio A. Freitas,et al.  Indexation as a Novel Mechanism of Lymphocyte Homeostasis: The Number of CD4+CD25+ Regulatory T Cells Is Indexed to the Number of IL-2-Producing Cells1 , 2006, The Journal of Immunology.

[133]  R. Zinkernagel,et al.  Antiviral immune responses in mice deficient for both interleukin-2 and interleukin-4 , 1995, Journal of virology.

[134]  T. Malek,et al.  Selective Availability of IL-2 Is a Major Determinant Controlling the Production of CD4+CD25+Foxp3+ T Regulatory Cells1 , 2006, The Journal of Immunology.

[135]  P. Burkett,et al.  Diverse functions of IL-2, IL-15, and IL-7 in lymphoid homeostasis. , 2006, Annual review of immunology.

[136]  I. Mackay,et al.  IL-2 receptor alpha deficiency and features of primary biliary cirrhosis. , 2006, Journal of autoimmunity.

[137]  Simon C. Potter,et al.  Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls , 2007, Nature.

[138]  Mark M Davis,et al.  T cells use two directionally distinct pathways for cytokine secretion , 2006, Nature Immunology.

[139]  A. Feller,et al.  Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene , 1993, Cell.

[140]  E. Rothenberg,et al.  Preferential Activation of an IL-2 Regulatory Sequence Transgene in TCRγδ and NKT Cells: Subset-Specific Differences in IL-2 Regulation1 , 2004, The Journal of Immunology.

[141]  Ian A Wilson,et al.  Crystal structure of the IL-2 signaling complex: paradigm for a heterotrimeric cytokine receptor. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[142]  A. Caudy,et al.  CD25 deficiency causes an immune dysregulation, polyendocrinopathy, enteropathy, X-linked-like syndrome, and defective IL-10 expression from CD4 lymphocytes. , 2007, The Journal of allergy and clinical immunology.

[143]  R. Simpson,et al.  Identification of the human 26-kD protein, interferon beta 2 (IFN-beta 2), as a B cell hybridoma/plasmacytoma growth factor induced by interleukin 1 and tumor necrosis factor , 1987, The Journal of experimental medicine.

[144]  S. Kim-Schulze,et al.  Characterization of CD4+CD25+ regulatory T cells in patients treated with high-dose interleukin-2 for metastatic melanoma or renal cell carcinoma. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[145]  F. Alt,et al.  Interleukin-2 receptor alpha chain regulates the size and content of the peripheral lymphoid compartment. , 1995, Immunity.

[146]  A. Abbas,et al.  IL-2 Induces a Competitive Survival Advantage in T Lymphocytes1 , 2004, The Journal of Immunology.

[147]  Fiona Powrie,et al.  Analysis of FOXP3 protein expression in human CD4+CD25+ regulatory T cells at the single‐cell level , 2005, European journal of immunology.

[148]  H. Colten,et al.  Cachectin/tumor necrosis factor regulates hepatic acute-phase gene expression. , 1986, The Journal of clinical investigation.

[149]  J. Bluestone,et al.  Cutting Edge: CD28 Controls Peripheral Homeostasis of CD4+CD25+ Regulatory T Cells 1 , 2003, The Journal of Immunology.

[150]  S. Yonehara,et al.  Normal clonal expansion but impaired Fasmediated cell death and anergy induction in interleukin‐2‐deficient mice , 1995, European journal of immunology.

[151]  A. Rudensky,et al.  Thymic development and peripheral homeostasis of regulatory T cells. , 2007, Current opinion in immunology.

[152]  A. Cumano,et al.  Ontogeny, function, and peripheral homeostasis of regulatory T cells in the absence of interleukin-7. , 2006, Blood.

[153]  Ethan M. Shevach,et al.  Cutting Edge: IL-2 Is Critically Required for the In Vitro Activation of CD4+CD25+ T Cell Suppressor Function , 2004, The Journal of Immunology.

[154]  Benedict Seddon,et al.  Interleukin 7 and T cell receptor signals regulate homeostasis of CD4 memory cells , 2003, Nature Immunology.

[155]  W. Paul,et al.  Neonates support lymphopenia-induced proliferation. , 2003, Immunity.

[156]  T. Malek,et al.  Function of the IL-2R for Thymic and Peripheral CD4+CD25+ Foxp3+ T Regulatory Cells1 , 2007, The Journal of Immunology.

[157]  L. Pulliam,et al.  Comparison of Leukocytic Pyrogen and Leukocytic Endogenous Mediator , 1977, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[158]  Z. Dai,et al.  The Dual Role of IL-2 in the Generation and Maintenance of CD8+ Memory T Cells1 , 2000, The Journal of Immunology.

[159]  Jean Imbert,et al.  Both integrated and differential regulation of components of the IL-2/IL-2 receptor system. , 2006, Cytokine & growth factor reviews.

[160]  Shimon Sakaguchi,et al.  Foxp3-dependent and -independent molecules specific for CD25+CD4+ natural regulatory T cells revealed by DNA microarray analysis. , 2006, International immunology.

[161]  R. Flavell,et al.  The selective ablation of interleukin 2-producing cells isolated from transgenic mice , 1993, The Journal of experimental medicine.

[162]  P. Greenberg,et al.  Selective Delivery of Augmented IL-2 Receptor Signals to Responding CD8+ T Cells Increases the Size of the Acute Antiviral Response and of the Resulting Memory T Cell Pool1 , 2002, The Journal of Immunology.

[163]  M. Farrar,et al.  IL-2 Receptor β-Dependent STAT5 Activation Is Required for the Development of Foxp3+ Regulatory T Cells1 , 2007, The Journal of Immunology.

[164]  T. Waldmann.  Daclizumab (anti-Tac, Zenapax) in the treatment of leukemia/lymphoma , 2007, Oncogene.

[165]  M. Alegre,et al.  Transgenic Expression of CTLA-4 Controls Lymphoproliferation in IL-2-Deficient Mice1 , 2004, The Journal of Immunology.

[166]  D. Willerford,et al.  Regulation of Lymphoid Homeostasis by IL-2 Receptor Signals In Vivo1 , 2000, The Journal of Immunology.

[167]  T. Waldmann,et al.  Contrasting roles of IL-2 and IL-15 in the life and death of lymphocytes: implications for immunotherapy. , 2001, Immunity.

[168]  I. Autenrieth,et al.  Interleukin-2 is indispensable for development of immunological self-tolerance. , 1996, Clinical immunology and immunopathology.

[169]  T. Mak,et al.  Requirement of the IL-2 Receptor β Chain for the Development of Vγ3 Dendritic Epidermal T Cells , 1998 .

[170]  L. Klein,et al.  Development and function of agonist-induced CD25+Foxp3+ regulatory T cells in the absence of interleukin 2 signaling , 2005, Nature Immunology.

[171]  B. Beutler,et al.  Cachectin and tumour necrosis factor as two sides of the same biological coin , 1986, Nature.

[172]  R. J. Hocking,et al.  TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. , 2006, Immunity.

[173]  A. Freitas,et al.  Homeostasis of Peripheral CD4+ T Cells: IL-2Rα and IL-2 Shape a Population of Regulatory Cells That Controls CD4+ T Cell Numbers1 , 2002, The Journal of Immunology.

[174]  W. Wood,et al.  The pathogenesis of fever , 1955 .

[175]  Cristina M. Tato,et al.  Helper T cell IL-2 production is limited by negative feedback and STAT-dependent cytokine signals , 2007, The Journal of experimental medicine.

[176]  Yan Zhou,et al.  Normal regulatory alpha/beta T cells effectively eliminate abnormally activated T cells lacking the interleukin 2 receptor beta in vivo. , 1999 .

[177]  L. Hennighausen,et al.  Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation. , 2007, Immunity.

[178]  J. Saklatvala,et al.  Pig interleukin 1. Purification of two immunologically different leukocyte proteins that cause cartilage resorption, lymphocyte activation, and fever , 1985, The Journal of experimental medicine.

[179]  R. Ahmed,et al.  CD4+ and CD8+ T cell interactions in IFN-gamma and IL-4 responses to viral infections: requirements for IL-2. , 1998, Journal of immunology.

[180]  Y. Wan,et al.  Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression , 2007, Nature.

[181]  T. Malek,et al.  Tolerance, not immunity, crucially depends on IL-2 , 2004, Nature Reviews Immunology.

[182]  R. Neta,et al.  Interleukin 1 is a radioprotector. , 1986, Journal of immunology.

[183]  J. Lowenthal,et al.  Binding and internalization of interleukin 1 by T cells. Direct evidence for high- and low-affinity classes of interleukin 1 receptor , 1986, The Journal of experimental medicine.

[184]  F. Brombacher,et al.  IL-2 promoter-driven lacZ expression as a monitoring tool for IL-2 expression in primary T cells of transgenic mice. , 1994, International immunology.

[185]  A. Chang,et al.  Cutting Edge: Th17 and Regulatory T Cell Dynamics and the Regulation by IL-2 in the Tumor Microenvironment1 , 2007, The Journal of Immunology.

[186]  W. Wood,et al.  Further purification of rabbit leukocyte pyrogen. , 1974, The Journal of laboratory and clinical medicine.

[187]  Ethan M. Shevach,et al.  CD4+CD25+ Immunoregulatory T Cells Suppress Polyclonal T Cell Activation In Vitro by Inhibiting Interleukin 2 Production , 1998, The Journal of experimental medicine.

[188]  T. Huizinga,et al.  Transient expression of FOXP3 in human activated nonregulatory CD4+ T cells , 2007, European journal of immunology.

[189]  T. Malek,et al.  Efficient Internalization of IL-2 Depends on the Distal Portion of the Cytoplasmic Tail of the IL-2R Common γ-Chain and a Lymphoid Cell Environment1 , 2000, The Journal of Immunology.

[190]  J. Vane,et al.  Inflammation and the mechanism of action of anti‐inflammatory drugs , 1987, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[191]  K. Mossman.  The Wellcome Trust Case Control Consortium, U.K. , 2008 .

[192]  R. Noelle,et al.  Generalized autoimmune disease in interleukin‐2‐deficient mice is triggered by an uncontrolled activation and proliferation of CD4+ T cells , 1995, European journal of immunology.

[193]  L. Lefrançois,et al.  Essential Role for IL-2 in the Regulation of Antiviral Extralymphoid CD8 T Cell Responses1 , 2002, The Journal of Immunology.

[194]  C. Clendenin,et al.  Defective thymocyte proliferation and IL-2 production in transgenic mice expressing a dominant-negative form of CREB , 1996, Nature.

[195]  J. Orange,et al.  Endogenous IL-2 contributes to T cell expansion and IFN-gamma production during lymphocytic choriomeningitis virus infection. , 1995, Journal of immunology.

[196]  T. Malek,et al.  The Role of IL-2 in the Development and Peripheral Homeostasis of Naturally Occurring CD4 + CD25 + Foxp3 + Regulatory T Cells , 2008 .

[197]  Shimon Sakaguchi,et al.  Homeostatic maintenance of natural Foxp3 + CD25+ CD4+ regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization , 2005, The Journal of experimental medicine.

[198]  K. Wolslegel,et al.  Interleukin-2 enhances CD4+ T cell memory by promoting the generation of IL-7Rα–expressing cells , 2007, The Journal of experimental medicine.

[199]  Li Li,et al.  Conversion of Peripheral CD4+CD25− Naive T Cells to CD4+CD25+ Regulatory T Cells by TGF-β Induction of Transcription Factor Foxp3 , 2003, The Journal of experimental medicine.

[200]  L. Turka,et al.  PTEN inhibits IL-2 receptor-mediated expansion of CD4+ CD25+ Tregs. , 2006, The Journal of clinical investigation.

[201]  P. Nickerson,et al.  IL-2 and IL-4 double knockout mice reject islet allografts: a role for novel T cell growth factors in allograft rejection. , 1998, Journal of immunology.

[202]  Nonredundant roles for Stat5a/b in directly regulating Foxp3. , 2007, Blood.

[203]  A. Rudensky,et al.  Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell development. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[204]  L. Lefrançois,et al.  Frontline: An in‐depth evaluation of the production of IL‐2 by antigen‐specific CD8 T cells in vivo , 2004, European journal of immunology.

[205]  T. Malek,et al.  Essential role for interleukin-2 for CD4+CD25+ T regulatory cell development during the neonatal period , 2005, The Journal of experimental medicine.

[206]  Steven M. Chan,et al.  Murine CD4+CD25+ Regulatory T Cells Fail to Undergo Chromatin Remodeling Across the Proximal Promoter Region of the IL-2 Gene1 , 2004, The Journal of Immunology.

[207]  R. Lechler,et al.  Activated CD1d‐restricted natural killer T cells secrete IL‐2: innate help for CD4+CD25+ regulatory T cells? , 2005, European journal of immunology.

[208]  M. Battaglia,et al.  Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells. , 2005, Blood.

[209]  T. Malek,et al.  Quantitative assessment concerning the contribution of IL-2Rbeta for superantigen-mediated T cell responses in vivo. , 2006, International immunology.

[210]  T. Waldmann,et al.  Regulatory CD56(bright) natural killer cells mediate immunomodulatory effects of IL-2Ralpha-targeted therapy (daclizumab) in multiple sclerosis. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[211]  H. Weiner,et al.  Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells , 2006, Nature.

[212]  J. Todd,et al.  Congenic mapping of the type 1 diabetes locus, Idd3, to a 780-kb region of mouse chromosome 3: identification of a candidate segment of ancestral DNA by haplotype mapping. , 2000, Genome research.

[213]  W. Leonard.  Cytokines and immunodeficiency diseases , 2001, Nature Reviews Immunology.

[214]  C. Dinarello.  Interleukin-1: amino acid sequences, multiple biological activities and comparison with tumor necrosis factor (cachectin). , 1986, The Year in immunology.

[215]  Ronald H. Schwartz,et al.  IL-2 Secretion by CD4+ T Cells In Vivo Is Rapid, Transient, and Influenced by TCR-Specific Competition , 2004, The Journal of Immunology.

[216]  E. Rothenberg,et al.  Spontaneous Expression of Interleukin-2 In Vivo in Specific Tissues of Young Mice , 1998, Developmental immunology.

[217]  J. Lohr,et al.  Sequential development of interleukin 2–dependent effector and regulatory T cells in response to endogenous systemic antigen , 2005, The Journal of experimental medicine.

[218]  D. Green,et al.  Duration of CTL activation regulates IL‐2 production required for autonomous clonal expansion , 2006, European journal of immunology.